Ledraxen

Enoxaparin Sodium, the active ingredient in Ledraxen, is a low molecular weight heparin presented as a sterile solution for subcutaneous or intravenous use. It is employed to prevent and treat venous thromboembolism in patients at risk of clot formation.

GNH USA supplies Ledraxen as a licensed, GDP‑compliant international pharmaceutical supplier, meeting stringent quality standards and serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring reliable global distribution.

Ledraxen, a low molecular weight heparin, is used in the management of venous thromboembolic disorders.

- Deep vein thrombosis (prevention): reduces risk of clot formation in at‑risk patients. - Deep vein thrombosis (treatment): facilitates resolution of existing thrombus and prevents extension. - Pulmonary embolism (prevention and treatment): lowers incidence of embolic events in the lungs. - Anticoagulation during hemodialysis: maintains circuit patency by preventing clotting.

Adverse reactions to Ledraxen may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Injection site bruising or pain. - Minor bleeding such as epistaxis or gum bleeding. - Nausea or vomiting. - Headache. - Elevated liver enzymes. - Transient increase in serum potassium.

Serious or Rare Side Effects: - Heparin‑induced thrombocytopenia (HIT). - Major bleeding, including intracranial hemorrhage. - Spinal or epidural hematoma. - Severe allergic reactions or anaphylaxis. - Liver dysfunction. - Thrombosis paradoxically despite therapy.

When prescribing Ledraxen, clinicians should consider several safety measures.

- Renal impairment: assess renal function and adjust dose as needed. - Pregnancy: use only if potential benefit justifies risk to fetus. - Surgery or invasive procedures: discontinue before major surgery to reduce bleeding risk. - Concomitant anticoagulants or antiplatelet agents: monitor for additive bleeding. - Platelet count monitoring: check regularly for signs of HIT. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ledraxen may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Concurrent use with other anticoagulants (e.g., warfarin, direct thrombin inhibitors). - Combination with NSAIDs, aspirin, or other antiplatelet drugs. - Administration with thrombolytic agents. - Spinal or epidural anesthesia/analgesia. - Use with systemic fibrinolytics.

Moderate Interactions (Monitor Closely): - Antiplatelet agents such as clopidogrel. - Certain antibiotics (e.g., vancomycin) that may increase bleeding risk. - Corticosteroids: may potentiate anticoagulant effect. - Renally cleared drugs requiring dose adjustment. - Herbal supplements like ginkgo or garlic.